Middle aged woman with depression, lost hope of getting better.

A 50-year-old woman with recurrent depression requested to be seen.

The patient expressed frustration and a loss of trust in the antidepressants due to their lack of efficacy and unacceptable side effects. She stated they made her stoic and felt like she was not her usual self. 

We offered Esketamine initially without any antidepressant. She was hesitant because of its potential for addiction or its lack of effectiveness. The patient had some knowledge of this medication from her background in pharmacology. 

We explained to her in detail, through pictures, how this drug actually works and answered all the questions. She felt better about it.  We were unable to start the treatment due to high blood pressure during the exam.  Her BP was stabilized by her family physician. 

Treatment was started twice per week in the first month. After 4 treatments, we didn't see any improvement (ideally, some improvement is usually noticed after the first treatment itself). We discussed and increased her dose to 84 mg per treatment visit. There was still just a mediocre response. 

We sat down with her and discussed our plan to add an oral antidepressant because esketamine (Spravato) is approved in combination with an antidepressant, so ideally it should be taken that way.  She was hesitant due to previous experience but agreed. 

We recommended Vortioxetine (Trintellix) due to its unique mechanism of action and better side-effect profile.  As we went into more treatment visits with esketamine, her symptoms progressively improved, and we had no adverse effects with the addition of Trintellix. 

At a follow-up call, the patient stated to me that what she is feeling now is a ''miracle''. She had never thought that this combination would help her so much. The patient was so pleased that she requested maintenance treatment with Esketamine which is given once a month. 

Author
Mazhar Golewale MD Board Certified Psychiatrist and Medical Director of Suburban Behavioral Health Services

You Might Also Enjoy...

TMS

What is TMS?

TMS is a non-invasive brain stimulation therapy that uses gentle magnetic stimulation on specific areas of the brain involved in mood regulation.

What is SPRAVATO®?

What it is: SPRAVATO® is a nasal spray version of esketamine, a form of ketamine approved by the FDA for treatment-resistant depression and depressive symptoms in adults with suicidal thoughts.

What it is IV Ketamine?

IV Ketamine is an off-label treatment using low doses of ketamine (a general anesthetic) to rapidly reduce symptoms. Current evidence has shown improvements in patients with treatment-resistant depression, bipolar depression, and anxiety disorders.

Understanding Alternatives for Treatment-Resistant Depression

Medications are not your only option! If you or a loved one are living with treatment-resistant depression, you’re not alone—and you do have options. Here are three advanced treatments that may offer relief when traditional antidepressants haven’t worked.

Erika Thiel, PA-S

Recognition and treatment of Obstructive Sleep Apnea(OSA)is extremely important especially in patient with mental illness.
TBI

Psychiatric Evaluation and Treatment Following TBI

Depression in Traumatic Brain injury (TBI) is very common. TBI occurs due to variety of reasons like Motor vehicle accidents, Sports injuries, Falls etc. Treatment of depression in TBI is challenging. We are presenting real case of a 56 yo woman.